Remove Bacteria Remove Development Remove In-Vitro Remove Reagent
article thumbnail

Reflecting on ELRIG’s Drug Discovery 2022 

Drug Discovery World

Over the two days at ExCel, 1554 delegates attended the event. Of those delegates, 75% work in drug discovery. There were 127 exhibitors, 180 posters, 40 technology speakers, 52 scientific speakers as well as a series of eight seminars focused on automation and technology which DDW organised and moderated in the dedicated Tech Theatre. .

Drugs 52
article thumbnail

Rising Demand for DNA and Gene Cloning  Service Providers

Roots Analysis

These clones can be manipulated and mutated in vitro to alter the expression and function of a protein. DNA and Gene Cloning involves the isolation of a DNA sequence of any species ( often a gene ) and its insertion into a vector to enable growth without any alteration in the original DNA sequence.

DNA 40
article thumbnail

The evolution of assays for immuno-oncology research

Drug Discovery World

The first such research dates back to 1891, when William Coley attempted to inject heat-inactivated bacteria to treat osteosarcoma. Further discovery of PD-1 and CTLA4 as negative immune regulators led to the development of a new class of cancer therapeutics, namely the immune checkpoint inhibitors 5,6.